摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

克立硼罗杂质Z9 | 906673-43-6

中文名称
克立硼罗杂质Z9
中文别名
——
英文名称
4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzoic acid
英文别名
5-(4-carboxyphenoxy)-1-hydroxy-2,1-benzoxaborole;5-(4-carboxyphenoxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole;Crisaborole acid impurity;4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzoic acid
克立硼罗杂质Z9化学式
CAS
906673-43-6
化学式
C14H11BO5
mdl
——
分子量
270.049
InChiKey
BYVNFPQXJOQGEM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.39
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    76
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS
    申请人:Baker J. Stephen
    公开号:US20070293457A1
    公开(公告)日:2007-12-20
    Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.
    本发明揭示了使用含小分子治疗抗炎症状况的方法。
  • Boron-containing small molecules
    申请人:Baker J. Stephen
    公开号:US20060234981A1
    公开(公告)日:2006-10-19
    This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
    本发明涉及用于治疗真菌感染的化合物,更具体地涉及用于局部治疗甲真菌病和/或皮肤真菌感染的化合物。本发明涉及对真菌具有活性并具有性质的化合物,使得当该化合物与患者接触时,能够到达被真菌感染的皮肤、指甲、头发、爪或蹄的特定部位。特别地,本发明的化合物具有物理化学性质,以促进穿透指甲板。
  • Boron-containing small molecules as anti-inflammatory agents
    申请人:Anacor Pharmaceuticals, Inc.
    公开号:US08039450B2
    公开(公告)日:2011-10-18
    Compounds and methods of treating anti-inflammatory conditions are disclosed.
    本发明揭示了治疗抗炎症状况的化合物和方法。
  • Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
    作者:Tsutomu Akama、Stephen J. Baker、Yong-Kang Zhang、Vincent Hernandez、Huchen Zhou、Virginia Sanders、Yvonne Freund、Richard Kimura、Kirk R. Maples、Jacob J. Plattner
    DOI:10.1016/j.bmcl.2009.03.007
    日期:2009.4
    A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release. 5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo. This compound is now in clinical development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis. (C) 2009 Elsevier Ltd. All rights reserved.
  • Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application
    作者:Yong-Kang Zhang、Jacob J. Plattner、Tsutomu Akama、Stephen J. Baker、Vincent S. Hernandez、Virginia Sanders、Yvonne Freund、Richard Kimura、Wei Bu、Karin M. Hold、Xiao-Song Lu
    DOI:10.1016/j.bmcl.2010.02.010
    日期:2010.4
    PDE4 inhibitors are a validated approach as anti-inflammatory agents but are limited by systemic side effects including emesis. We report a soft-drug strategy incorporating a carboxylic ester group into boron-containing PDE4 inhibitors leading to the discovery of a series of benzoxaborole compounds with good potency (for example IC(50) = 47 nM of compound 2) and low emetic activity. These compounds are intended for dermatological use further limiting possible systemic side effects. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多